Cellectis announced the presentation of preclinical data supporting .HEAL-101, its in vivo base editing product candidate ...

APOC3 in a single administration76% triglyceride reduction after a single dose in murine disease modelNEW YORK, Oct.

High demand for the Toyota RAV4 has pushed used vehicles prices above the cost of new models for some car shoppers. Here's ...

LCI Industries confirmed on October 28, 2026, that it has received an unsolicited, non-binding proposal from Monomoy Capital Partners to acquire LCI for $101 per share in cash. Consistent with its ...

As AI models grow increasingly powerful and sophisticated, the significance of robust capital accounting practices rises in ...

Lamassu Biotech today announced initial safety and pharmacokinetic data from the ongoing first-in-human Phase 1/2a clinical trial (LB-SA53-101) of SA53, an oral MDM2 inhibitor, at the European Society ...

ZURICH--AL-S Pharma AG ("AL-S Pharma" or "the Company"), a clinical-stage biotechnology company discovering and developing human antibodies that target misfolded proteins implicated in amyotrophic ...

October 26, 2026) - BCM Resources Corporation (TSXV: B) ("BCM" or the "Company") is pleased to announce that recently completed geophysical surveys are beginning to highlight new prospective targets ...

Cellectis plans a Phase 1 investigator-initiated trial (IIT) in China, with preliminary clinical data expected in the second half of 2027. CLLS closed Tuesday at $1.05, up 8.64%.

A multicenter retrospective study of 101 patients defines the CT, MRI and PET/CT features of primary pulmonary artery sarcoma ...

ChatGPT, Claude and Grok weigh Solana, Zcash and Monero for year-end. Here's the best crypto to hold and each model's targets ...

These data lend support for Faeth’s multi-node strategy, with two upcoming readouts: FTH-PIK-201 topline data in second-line advanced endometrial cancer by year-end 2026 and FTH-PIK-101 interim data ...